Respiratory Science Webinars

Experts present two novel animal models of COVID-19 and highlight recent research conducted using these models.

Experts discuss how automated microscopy and image analysis can quantify critical markers of infection and describe the insight provided by microscopy in the context of SARS-CoV-2 infection and inflammation.

Hayley Crawford, PhD, and Carl Marci, MD, discuss how their specific industries have developed new innovations in response to the COVID-19 pandemic.

The 2022 InsideScientific Research Technology & Innovation Summits focus on specific research and therapeutic areas, reviewing how novel technologies and innovative services are advancing discovery in each particular field.

Dr. Emma Karey presents research that challenges the convention that extant cigarette endpoints sufficiently capture the health risks of vaping, and provides a translational framework for how to integrate scientific principles and novel conditions.

Dr. Xuebin Qin discusses the development and characterization of new models of SARS-CoV-2 and HIV, and how his lab uses these models to study cardiovascular injury associated with infection.

During this webinar, experts from Imperial College Healthcare NHS Trust describe the presenting symptoms and diagnostic challenges for patients in their syncope clinic presenting with autonomic dysfunction in Long-COVID.

A virtual conference to celebrate the 20-year anniversary of TRPV4 and discuss its importance across various biological systems and associated disease models.

Allison Rodgers discusses the value of imaging the mouse right ventricle and lungs using high-frequency ultrasound for models of cardiopulmonary physiology and associated diseases.

Dr. Brendan Dougherty discusses how sex hormones influence respiratory function and the development of respiratory neuroplasticity.

Join BIOPAC to learn more about technologies and techniques to help you record good quality respiration data. 

Renowned MRI expert, Prof. Jim Wild, will discuss the clinical applications of 129Xe lung imaging with a focus on novel pulmonary therapies using hyperpolarized gas and proton lung MRI as markers.